ELEV
Vanguard Group’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Sell |
2,256,690
-328,530
| -13% | -$121K | ﹤0.01% | 3790 |
|
|
2025
Q1 | $670K | Sell |
2,585,220
-24,825
| -1% | -$6.43K | ﹤0.01% | 3816 |
|
|
2024
Q4 | $1.47M | Sell |
2,610,045
-461,535
| -15% | -$260K | ﹤0.01% | 3649 |
|
|
2024
Q3 | $1.84M | Buy |
3,071,580
+1,154,537
| +60% | +$693K | ﹤0.01% | 3583 |
|
|
2024
Q2 | $5.18M | Buy |
1,917,043
+384,998
| +25% | +$1.04M | ﹤0.01% | 3247 |
|
|
2024
Q1 | $7.86M | Buy |
1,532,045
+360,799
| +31% | +$1.85M | ﹤0.01% | 3097 |
|
|
2023
Q4 | $629K | Buy |
1,171,246
+101,441
| +9% | +$54.5K | ﹤0.01% | 3965 |
|
|
2023
Q3 | $709K | Sell |
1,069,805
-5,352
| -0.5% | -$3.55K | ﹤0.01% | 3947 |
|
|
2023
Q2 | $1.63M | Buy |
1,075,157
+619,376
| +136% | +$941K | ﹤0.01% | 3729 |
|
|
2023
Q1 | $866K | Buy |
455,781
+122,473
| +37% | +$233K | ﹤0.01% | 3964 |
|
|
2022
Q4 | $317K | Buy |
333,308
+284
| +0.1% | +$270 | ﹤0.01% | 4211 |
|
|
2022
Q3 | $376K | Sell |
333,024
-67,829
| -17% | -$76.6K | ﹤0.01% | 4290 |
|
|
2022
Q2 | $561K | Buy |
400,853
+24,700
| +7% | +$34.6K | ﹤0.01% | 4261 |
|
|
2022
Q1 | $948K | Sell |
376,153
-4,660
| -1% | -$11.7K | ﹤0.01% | 4225 |
|
|
2021
Q4 | $2.29M | Sell |
380,813
-274,596
| -42% | -$1.65M | ﹤0.01% | 3988 |
|
|
2021
Q3 | $5.11M | Buy |
655,409
+595,409
| +992% | +$4.64M | ﹤0.01% | 3643 |
|
|
2021
Q2 | $814K | Buy |
+60,000
| New | +$814K | ﹤0.01% | 4190 |
|